إبر التخسيس (GLP-1) ولا جراحات السمنة؟ الاختيار حسب حالتك | Ozempic and Mounjaro vs. Bariatric Surgery: Which Is Right for You?
الاختيار حسب كتلة الجسم | Choosing by BMI
إبر الـ GLP-1 زي الساكسندا والمونجارو والأوزمبيك بقت من أشهر طرق نزول الوزن، لكن الاختيار بينها وبين جراحات السمنة (Bariatric surgery) لازم يكون بتقييم جراح السمنة. د. محمد حسام زيدان بيوضح بأمثلة: مريض كتلة جسمه 40 ومعاه أمراض مصاحبة زي الضغط أو السكر، الأفضل له غالبًا عملية زي تكميم المعدة أو تحويل المسار، أما مريض كتلة جسمه من 30 لـ 33 ومن غير أمراض مصاحبة فممكن تناسبه أدوية الـ GLP-1. والقرار في الآخر بيعتمد على تقييم كل مريض. | GLP-1-based injections such as Saxenda, Mounjaro and Ozempic have become one of the most popular ways to lose weight, but choosing between them and bariatric surgery should be done with a bariatric surgeon's assessment. Dr. Mohamed H. Zidan gives examples: a patient with a BMI of 40 and obesity-related conditions such as high blood pressure or diabetes is usually better served by an operation such as sleeve gastrectomy or gastric bypass, while a patient with a BMI of 30 to 33 and no related conditions may be suited to GLP-1 medication. In the end, the decision depends on each patient's assessment.
Key Takeaways
Full Transcript
One of the most popular modern ways to lose weight is GLP-1 injections such as Saxenda, Mounjaro and Ozempic. These medications have taken a very large share of obesity treatment, but the choice between medication and surgery should really be made by a bariatric surgeon, so that we can assess obesity-related conditions and decide on the best way to lose weight. For example, a patient with a BMI of 40 who also has obesity-related conditions such as high blood pressure or diabetes is better served by an operation such as sleeve gastrectomy or gastric bypass. Another patient, with a BMI of 30 to 33 and no obesity-related conditions, is better suited to a treatment such as GLP-1 medication. That's why every patient should be assessed.